Literature DB >> 17916204

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.

R Krishnan, D Cella, C Leonardi, K Papp, A B Gottlieb, M Dunn, C F Chiou, V Patel, A Jahreis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17916204     DOI： 10.1111/j.1365-2133.2007.08205.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  35 in total

Review 1.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

Review 2.  Integrating neuroimmune systems in the neurobiology of depression.

Authors:  Eric S Wohleb; Tina Franklin; Masaaki Iwata; Ronald S Duman
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

3.  Inflammatory biomarkers in depression: an opportunity for novel therapeutic interventions.

Authors:  Madeline Li; Joanna K Soczynska; Sidney H Kennedy
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 4.  Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Authors:  Emilie Sbidian; Anna Chaimani; Ignacio Garcia-Doval; Giao Do; Camille Hua; Canelle Mazaud; Catherine Droitcourt; Carolyn Hughes; John R Ingram; Luigi Naldi; Olivier Chosidow; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2017-12-22

Review 5.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

6.  Prepregnancy Obesity and a Biobehavioral Predictive Model for Postpartum Depression.

Authors:  Sharon L Ruyak; Nancy K Lowe; Elizabeth J Corwin; Madalynn Neu; Blake Boursaw
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2016-03-24

Review 7.  Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.

Authors:  Ebrahim Haroon; Charles L Raison; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2011-09-14       Impact factor: 7.853

Review 8.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

Authors:  Rushaniya A Khairova; Rodrigo Machado-Vieira; Jing Du; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-19       Impact factor: 5.176

9.  Skimmetin/osthole mitigates pain-depression dyad via inhibiting inflammatory and oxidative stress-mediated neurotransmitter dysregulation.

Authors:  Lovedeep Singh; Anudeep Kaur; Saweta Garg; Rajbir Bhatti
Journal:  Metab Brain Dis       Date:  2020-09-01       Impact factor: 3.584

10.  An altered peripheral IL6 response in major depressive disorder.

Authors:  Kelli M Money; Zita Olah; Zeljka Korade; Krassimira A Garbett; Richard C Shelton; Karoly Mirnics
Journal:  Neurobiol Dis       Date:  2016-01-22       Impact factor: 5.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.